
A new $4.25 million gene therapy for a rare disease has been approved by the FDA, highlighting the rapid growth and high costs within the gene therapy sector.

The EPA's new tailpipe emission standards will force automakers to accelerate the shift to electric vehicles by 2032 to meet strict climate goals.

Mortgage rates are dipping and realtor commissions face cuts, offering a glimmer of hope for prospective US homebuyers in a historically tough market.


US manufacturers are adopting AI and robotics to pursue zero-defect goals and lower quality-related costs amid shifts toward vertical integration.


New rules allow for negotiable real estate commissions, potentially saving sellers thousands as the industry shifts away from traditional fee models.



